Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 41
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

CROSSalive: a web server for predicting the in vivo structure of RNA molecules

  • Delli Ponti, Riccardo, 1987-
  • Armaos, Alexandros, 1989-
  • Vandelli, Andrea
  • Tartaglia, Gian Gaetano
MOTIVATION: RNA structure is difficult to predict in vivo due to interactions with enzymes and other molecules. Here we introduce CROSSalive, an algorithm to predict the single- and double-stranded regions of RNAs in vivo using predictions of protein interactions. RESULTS: Trained on icSHAPE data in presence (m6a+) and absence of N6 methyladenosine modification (m6a-), CROSSalive achieves cross-validation accuracies between 0.70 and 0.88 in identifying high-confidence single- and double-stranded regions. The algorithm was applied to the long non-coding RNA Xist (17 900 nt, not present in the training) and shows an Area under the ROC curve of 0.83 in predicting structured regions. AVAILABILITY AND IMPLEMENTATION: CROSSalive webserver is freely accessible at http://service.tartaglialab.com/new_submission/crossalive. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online., The research leading to these results has received funding from European Research Council RIBOMYLOME_309545, European Union's Horizon 2020 IASIS_727658 and INFORE_825070, as well as Spanish Ministry of Economy and Competitiveness BFU2017-86970-P
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

RNA-binding and prion domains: the Yin and Yang of phase separation

  • Lorenzo Gotor, Maria de las Nieves
  • Armaos, Alexandros, 1989-
  • Calloni, Giulia
  • Torrent Burgas, Marc
  • Vabulas, R. Martin
  • Sánchez de Groot, Natalia
  • Tartaglia, Gian Gaetano
Proteins and RNAs assemble in membrane-less organelles that organize intracellular spaces and regulate biochemical reactions. The ability of proteins and RNAs to form condensates is encoded in their sequences, yet it is unknown which domains drive the phase separation (PS) process and what are their specific roles. Here, we systematically investigated the human and yeast proteomes to find regions promoting condensation. Using advanced computational methods to predict the PS propensity of proteins, we designed a set of experiments to investigate the contributions of Prion-Like Domains (PrLDs) and RNA-binding domains (RBDs). We found that one PrLD is sufficient to drive PS, whereas multiple RBDs are needed to modulate the dynamics of the assemblies. In the case of stress granule protein Pub1 we show that the PrLD promotes sequestration of protein partners and the RBD confers liquid-like behaviour to the condensate. Our work sheds light on the fine interplay between RBDs and PrLD to regulate formation of membrane-less organelles, opening up the avenue for their manipulation., European Research Council (ERC) [RIBOMYLOME_309545 to G.G.T., ASTRA_855923 to G.G.T., METAMETA_311522 to R.M.V.]; Spanish Ministry of Economy and Competitiveness [BFU2014-55054-P, BFU2017-86970-P]; H2020 Projects [IASIS_727658, INFORE_825080]; ‘Centro de Excelencia Severo Ochoa 2013-2017’; CERCA Programme/Generalitat de Catalunya (to EMBL partnership); Spanish Ministry for Science and Competitiveness (MINECO) (to EMBL partnership). Funding for open access charge: ERC [855923].
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes

  • Cava, Claudia
  • Armaos, Alexandros, 1989-
  • Lang, Benjamin
  • Tartaglia, Gian Gaetano
  • Castiglioni, Isabella
Breast cancer is a heterogeneous disease classified into four main subtypes with different clinical outcomes, such as patient survival, prognosis, and relapse. Current genetic tests for the differential diagnosis of BC subtypes showed a poor reproducibility. Therefore, an early and correct diagnosis of molecular subtypes is one of the challenges in the clinic. In the present study, we identified differentially expressed genes, long non-coding RNAs and RNA binding proteins for each BC subtype from a public dataset applying bioinformatics algorithms. In addition, we investigated their interactions and we proposed interacting biomarkers as potential signature specific for each BC subtype. We found a network of only 2 RBPs (RBM20 and PCDH20) and 2 genes (HOXB3 and RASSF7) for luminal A, a network of 21 RBPs and 53 genes for luminal B, a HER2-specific network of 14 RBPs and 30 genes, and a network of 54 RBPs and 302 genes for basal BC. We validated the signature considering their expression levels on an independent dataset evaluating their ability to classify the different molecular subtypes with a machine learning approach. Overall, we achieved good performances of classification with an accuracy >0.80. In addition, we found some interesting novel prognostic biomarkers such as RASSF7 for luminal A, DCTPP1 for luminal B, DHRS11, KLC3, NAGS, and TMEM98 for HER2, and ABHD14A and ADSSL1 for basal. The findings could provide preliminary evidence to identify putative new prognostic biomarkers and therapeutic targets for individual breast cancer subtypes., The research leading to these results has been supported by European Research Council grant agreements RIBOMYLOME (309545) and ASTRA (855923), and the European Union’s Horizon 2020 research and innovation programme grant agreements IASIS (727658), DeepRNA (793135), and INFORE (825080). We would like to thank for the financial support the project Grant SysBioNet, Italian Roadmap Research Infrastructures 2012.
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches

  • Niarakis, Anna
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
  • COVID-19 Disease Map Community
Introduction: The COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing. Methods: Extensive community work allowed an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework can link biomolecules from omics data analysis and computational modelling to dysregulated pathways in a cell-, tissue- or patient-specific manner. Drug repurposing using text mining and AI-assisted analysis identified potential drugs, chemicals and microRNAs that could target the identified key factors. Results: Results revealed drugs already tested for anti-COVID-19 efficacy, providing a mechanistic context for their mode of action, and drugs already in clinical trials for treating other diseases, never tested against COVID-19. Discussion: The key advance is that the proposed framework is versatile and expandable, offering a significant upgrade in the arsenal for virus-host interactions and other complex pathologies., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AN acknowledges support from SANOFI-AVENTIS R&D via the CIFRE contract, n° 2020/0766. MK, FH, NP, FE, and CE acknowledge the support of the ZonMw COVID-19 programme (Grant No. 10430012010015). JD Spanish Ministry of Science and Innovation (Grant no. PID2020-117979RB-I00) and Instituto de Salud Carlos III (Grant no. IMP/00019). MAi, KK, FS: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 251654672 - TRR 161 and under Germany’s Excellence Strategy - EXC 2117 - 422037984. FM: “5 per 1000–2021” grant of the Italian Ministry of Health (Grant No. 5M-2021-23683787) and European Commission with HORIZON programme, BY-COVID project (Grant No. 101046203—BY-COVID). National Institute for Infectious Diseases Lazzaro Spallanzani–IRCCS received financial support from the Italian Ministry of Health grant “Ricerca Corrente”. JP, LF: IMI2-JU grants, resources which are composed of financial contributions from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA [GA: 777365 eTRANSAFE], and the EU H2020 Programme [GA:964537 RISKHUNT3R]; Project 001-P-001647—Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”). AMo, MP and AV acknowledge the support of the European Commission under the INFORE project (H2020-ICT-825070) and the PerMedCoE (H2020-ICT-951773). Contributions by TH and BLP were supported by NIH grant #R35GM119770 to TH. MaGo acknowledges funding from Deutsche Forschungsgemeinschaft (DFG) through grants no. 442326535 (NFDI4Health) and 451265285 (NFDI4Health Task Force COVID-19), from the European Commission through the Horizon 2020 framework program under grant no. 825843 (EU-STANDS4PM) and through the Digital Europe program under grant no. 101083771 (EDITH), as well as from the Klaus Tschira Foundation. AL acknowledges support from the Intramural Research Program of the National Library of Medicine (NLM), National Institutes of Health (NIH).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Long non-coding RNA-polycomb intimate rendezvous

  • Cerase, Andrea
  • Tartaglia, Gian Gaetano
The interaction between polycomb-repressive complexes 1/2 (PRC1/2) and long non-coding RNA (lncRNA), such as the X inactive specific transcript Xist and the HOX transcript antisense RNA (HOTAIR), has been the subject of intense debate. While cross-linking, immuno-precipitation and super-resolution microscopy argue against direct interaction of Polycomb with some lncRNAs, there is increasing evidence supporting the ability of both PRC1 and PRC2 to functionally associate with RNA. Recent data indicate that these interactions are in most cases spurious, but nonetheless crucial for a number of cellular activities. In this review, we suggest that while PRC1/2 recruitment by HOTAIR might be direct, in the case of Xist, it might occur indirectly and, at least in part, through the process of liquid-liquid phase separation. We present recent models of lncRNA-mediated PRC1/2 recruitment to their targets and describe potential RNA-mediated roles in the three-dimensional organization of the nucleus., A.C. had been funded by a Rett Syndrome Research Trust (RSRT) and a BARTS Charity grants and by QMUL intramural support. The research leading to these results has been supported by European Research Council (RIBOMYLOME 309545 and ASTRA 855923), the Spanish Ministry of Economy and Competitiveness (BFU2017-86970-P) and H2020 projects (IASIS 727658 and INFORE 825080).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

The interplay between disordered regions in RNAs and proteins modulates interactions within stress granules and processing bodies

  • Vandelli, Andrea
  • Cid Samper, Fernando, 1991-
  • Torrent Burgas, Marc
  • Sánchez de Groot, Natalia
  • Tartaglia, Gian Gaetano
Condensation, or liquid-like phase separation, is a phenomenon indispensable for the spatiotemporal regulation of molecules within the cell. Recent studies indicate that the composition and molecular organization of phase-separated organelles such as Stress Granules (SGs) and Processing Bodies (PBs) are highly variable and dynamic. A dense contact network involving both RNAs and proteins controls the formation of SGs and PBs and an intricate molecular architecture, at present poorly understood, guarantees that these assemblies sense and adapt to different stresses and environmental changes. Here, we investigated the physico-chemical properties of SGs and PBs components and studied the architecture of their interaction networks. We found that proteins and RNAs establishing the largest amount of contacts in SGs and PBs have distinct properties and intrinsic disorder is enriched in all protein-RNA, protein-protein and RNA-RNA interaction networks. The increase of disorder in proteins is accompanied by an enrichment in single-stranded regions of RNA binding partners. Our results suggest that SGs and PBs quickly assemble and disassemble through dynamic contacts modulated by unfolded domains of their components., The research leading to these results has been supported by European Research Council [RIBOMYLOME_309545 and ASTRA_855923], the H2020 projects [IASIS_727658 and INFORE_825080] and the Spanish Ministry of Science and Innovation (RYC2019-026752-I and PID2020-117454RA-I00).
Repositorio Digital de la UPF
Publication Artículo científico (JournalArticle)

Structural analysis of SARS-CoV-2 genome and predictions of the human interactome

  • Vandelli, Andrea
  • Monti, Michele
  • Milanetti, Edoardo
  • Armaos, Alexandros, 1989-
  • Rupert, Jakob
  • Zacco, Elsa
  • Bechara, Elias
  • Delli Ponti, Riccardo, 1987-
  • Tartaglia, Gian Gaetano
Specific elements of viral genomes regulate interactions within host cells. Here, we calculated the secondary structure content of >2000 coronaviruses and computed >100 000 human protein interactions with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The genomic regions display different degrees of conservation. SARS-CoV-2 domain encompassing nucleotides 22 500-23 000 is conserved both at the sequence and structural level. The regions upstream and downstream, however, vary significantly. This part of the viral sequence codes for the Spike S protein that interacts with the human receptor angiotensin-converting enzyme 2 (ACE2). Thus, variability of Spike S is connected to different levels of viral entry in human cells within the population. Our predictions indicate that the 5' end of SARS-CoV-2 is highly structured and interacts with several human proteins. The binding proteins are involved in viral RNA processing, include double-stranded RNA specific editases and ATP-dependent RNA-helicases and have strong propensity to form stress granules and phase-separated assemblies. We propose that these proteins, also implicated in viral infections such as HIV, are selectively recruited by SARS-CoV-2 genome to alter transcriptional and post-transcriptional regulation of host cells and to promote viral replication., European Research Council [RIBOMYLOME_309545, ASTRA_855923]; H2020 projects [IASIS_727658 and INFORE_825080]; Spanish Ministry of Economy and Competitiveness [BFU2017-86970-P]; collaboration with Peter St. George-Hyslop financed by the Wellcome Trust. Funding for open access charge: ERC [ASTRA 855923].
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

  • Ostaszewski, Marek
  • Niarakis, Anna
  • Mazein, Alexander
  • Kuperstein, Inna
  • Phair, Robert
  • Orta-Resendiz, Aurelio
  • Singh, Vidisha
  • Aghamiri, Sara Sadat
  • Acencio, Marcio Luis
  • Glaab, Enrico
  • Ruepp, Andreas
  • Schreiber, Falk
  • Montagud, Arnau
  • Ponce de León, Miguel
  • Funahashi, Akira
  • Hiki, Yusuke
  • Hiroi, Noriko
  • Yamada, Takahiro G.
  • Dräger, Andreas
  • Renz, Alina
  • Naveez, Muhammad
  • Orlic-Milacic, Marija
  • Bocskei, Zsolt
  • Messina, Francesco
  • Börnigen, Daniela
  • Fergusson, Liam
  • Conti, Marta
  • Rameil, Marius
  • Nakonecnij, Vanessa
  • Vanhoefer, Jakob
  • Schmiester, Leonard
  • Wang, Muying
  • Senff Ribeiro, Andrea
  • Ackerman, Emily E.
  • Shoemaker, Jason E.
  • Zucker, Jeremy
  • Oxford, Kristie
  • Teuton, Jeremy
  • Kocakaya, Ebru
  • Summak, Gökçe Yagmu
  • Hanspers, Kristina
  • Kutmon, Martina
  • Coort, Susan
  • Rothfels, Karen
  • Eijssen, Lars
  • Ehrhart, Friederike
  • Arokia Balaya Rex, Devasahayam
  • Slenter, Denise
  • Martens, Marvin
  • Pham, Nhung
  • Haw, Robin
  • Jassal, Bijay
  • Matthews, Lisa
  • Shamovsky, Veronic
  • Stephan, Ralf
  • Sevilla, Cristoffer
  • Varusai, Thawfeek
  • Ravel, Jean-Marie
  • Fraser, Rupsha
  • Ortseifen, Vera
  • Soliman, Sylvain
  • Marchesi, Silvia
  • Gawron, Piotr
  • Smula, Ewa
  • Heirendt, Laurent
  • Satagopam, Venkata
  • Wu, Guanming
  • Riutta, Anders
  • Golebiewski, Martin
  • Owen, Stuart
  • Goble, Carole
  • Valdeolivas, Alberto
  • Hu, Xiaoming
  • Overall, Rupert W.
  • Maier, Dieter
  • Bauch, Angela
  • Gyori, Benjamin M.
  • Bachman, John A.
  • Vega, Carlos
  • Groues, Valentin
  • Vázquez, Miguel
  • Porras, Pablo
  • Esteban-Medina, Marina
  • Licata, Luana
  • Iannuccelli, Marta
  • Sacco, Francesca
  • Nesterova, Anastasia
  • Yuryev, Anton
  • Waard, Anita de
  • Turei, Denes
  • Luna, Augustín
  • Babur, Ozgun
  • Peña-Chilet, María
  • Rian, Kinza
  • Helikar, Tomas
  • Lal Puniya, Bhanwar
  • Modos, Dezso
  • Treveil, Agatha
  • Olbe, Marton
  • Fobo, Gisela
  • De Meulder, Bertrand
  • Ballereau, Stephane
  • Dugourd, Aurelien
  • Naldi, Aurelien
  • Noël, Vincent
  • Calzone, Laurence
  • Sander, Chris
  • Demir, Emek
  • Korcsmaros, Tamas
  • Freeman, Tom C.
  • Montrone, Corinna
  • Auge, Franck
  • Beckmann, Jacques S.
  • Hasenauer, Jan
  • Wolkenhauer, Olaf
  • Wilighagen, Egon L .
  • Pico, Alexander R.
  • Evelo, Chris T.
  • Gillespie, Marc E.
  • Stein, Lincoln D.
  • Hermjakob, Henning
  • Brauner, Barbara
  • D’Eustachio, Peter
  • Sáez-Rodríguez, Julio
  • Dopazo, Joaquín
  • Valencia, Alfonso
  • Kitano, Hiroaki
  • Barillot, Emmanuel
  • Auffray, Charles
  • Balling, Rudi
  • Schneider, Reinhard
  • Frishman, Goar
  • Monraz Gómez, Luis Cristóbal
  • Somers, Julia
  • Hoch, Matti
  • Gupta, Shailendra Kumar
  • Scheel, Julia
  • Borlinghaus, Hanna
  • Czauderna, Tobias
We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort to build an open access, interoperable and computable repository of COVID-19 molecular mechanisms. The COVID-19 Disease Map (C19DMap) is a graphical, interactive representation of disease-relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph-based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS-CoV-2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID-19 or similar pandemics in the long-term perspective., This study was supported by the Luxembourg National Research Fund (FNR) COVID-19 Fast-Track grant programme, grant COVID-19/2020-1/14715687/CovScreen (E. Glaab); European Commission, INFORE grant H2020-ICT-825070 (A. Montagud, M. Ponce de Leon, M. Vazques and A. Valencia); European Commission, PerMedCoE grant H2020-ICT-951773 (A. Montagud, M. Ponce de Leon, M. Vazques and A. Valencia) the Federal Ministry of Education and Research (BMBF, Germany) and the Baden-Württemberg Ministry of Science, the Excellence Strategy of the German Federal and State Governments (A. Renz); German Center for Infection Research (DZIF), grant no 8020708703 (A. Dräger); The Netherlands Organisation for Health Research and Development (ZonMw), grant no 10430012010015, (M. Kutmon, S. Coort, F. Ehrhart, N. Pham, E.L. Willighagen, C.T. Evelo); H2020 Marie Skłodowska-Curie Actions, grant number 765274 (J. Scheel); National Institutes of Health, USA (NIH), grant number U41 HG003751 (L.D. Stein). The development of Reactome is supported by grants from the US National Institutes of Health (U41 HG003751) and the European Molecular Biology Laboratory.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches

  • Niarakis, Anna
  • Ostaszewski, Marek
  • Mazein, Alexander
  • Kuperstein, Inna
  • Kutmon, Martina
  • Gillespie, Marc E.
  • Funahashi, Akira
  • Acencio, Marcio Luis
  • Hemedan, Ahmed
  • Aichem, Michael
  • Klein, Karsten
  • Czauderna, Tobias
  • Burtscher, Felicia
  • Yamada, Takahiro G.
  • Hiki, Yusuke
  • Hiroi, Noriko F.
  • Hu, Finterly
  • Pham, Nhung
  • Ehrhart, Friederike
  • Willighagen, Egon L.
  • Valdeolivas, Alberto
  • Dugourd, Aurelien
  • Messina, Francesco
  • Esteban-Medina, Marina
  • Peña-Chilet, María
  • Rian, Kinza
  • Soliman, Sylvain
  • Aghamiri, Sara Sadat
  • Lal Puniya, Bhanwar
  • Naldi, Aurelien
  • Helikar, Tomas
  • Singh, Vidisha
  • Fariñas Fernández, Marco
  • Bermudez, Viviam
  • Tsirvouli, Eirini
  • Montagud, Arnau
  • Noël, Vincent
  • Ponce de León, Miguel
  • Maier, Dieter
  • Bauch, Angela
  • Gyori, Benjamin M.
  • Bachman, John A.
  • Luna, Augustin
  • Piñero, Janet
  • Furlong, Laura I.
  • Balaur, Irina BalaurIrina
  • Rougny, Adrien
  • Jarosz, Yohan
  • Overall, Rupert W.
  • Phair, Robert
  • Perfetto, Livia
  • Matthews, Lisa
  • Balaya Rex, Devasahayam Arokia
  • Orlic-Milacic, Marija
  • Monraz Gómez, Luis Cristóbal
  • De Meulder, Bertrand
  • Ravel, Jean-Marie
  • Jassal, Bijay
  • Satagopam, Venkata
  • Wu, Guanming
  • Golebiewski, Martin
  • Gawron, Piotr
  • Calzone, Laurence
  • Beckmann, Jacques S.
  • Evelo, Chris T.
  • D’Eustachio, Peter
  • Schreiber, Falk
  • Sáez-Rodríguez, Julio
  • Dopazo, Joaquín
  • Kuiper, Martin
  • Valencia, Alfonso
  • Wolkenhauer, Olaf
  • Kitano, Hiroaki
  • Barillot, Emmanuel
  • Auffray, Charles
  • Balling, Rudi
  • Schneider, Reinhard
  • COVID- Disease Map Community the COVID-19 Disease Map Community
© 2024 Niarakis, Ostaszewski, Mazein, Kuperstein, Kutmon, Gillespie, Funahashi, Acencio, Hemedan, Aichem, Klein, Czauderna, Burtscher, Yamada, Hiki, Hiroi, Hu, Pham, Ehrhart, Willighagen, Valdeolivas, Dugourd, Messina, Esteban-Medina, Peña-Chilet, Rian, Soliman, Aghamiri, Puniya, Naldi, Helikar, Singh, Fernández, Bermudez, Tsirvouli, Montagud, Noël, Ponce-de-Leon, Maier, Bauch, Gyori, Bachman, Luna, Piñero, Furlong, Balaur, Rougny, Jarosz, Overall, Phair, Perfetto, Matthews, Rex, Orlic-Milacic, Gomez, De Meulder, Ravel, Jassal, Satagopam, Wu, Golebiewski, Gawron, Calzone, Beckmann, Evelo, D’Eustachio, Schreiber, Saez-Rodriguez, Dopazo, Kuiper, Valencia, Wolkenhauer, Kitano, Barillot, Auffray, Balling, Schneider and the COVID-19 Disease Map Community. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms., Introduction: The COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing., Methods: Extensive community work allowed an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework can link biomolecules from omics data analysis and computational modelling to dysregulated pathways in a cell-, tissue- or patient-specific manner. Drug repurposing using text mining and AI-assisted analysis identified potential drugs, chemicals and microRNAs that could target the identified key factors., Results: Results revealed drugs already tested for anti-COVID-19 efficacy, providing a mechanistic context for their mode of action, and drugs already in clinical trials for treating other diseases, never tested against COVID-19., Discussion: The key advance is that the proposed framework is versatile and expandable, offering a significant upgrade in the arsenal for virus-host interactions and other complex pathologies., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AN acknowledges support from SANOFI-AVENTIS R&D via the CIFRE contract, n° 2020/0766. MK, FH, NP, FE, and CE acknowledge the support of the ZonMw COVID-19 programme (Grant No. 10430012010015). JD Spanish Ministry of Science and Innovation (Grant no. PID2020-117979RB-I00) and Instituto de Salud Carlos III (Grant no. IMP/00019). MAi, KK, FS: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 251654672 - TRR 161 and under Germany’s Excellence Strategy - EXC 2117 - 422037984. FM: “5 per 1000–2021” grant of the Italian Ministry of Health (Grant No. 5M-2021-23683787) and European Commission with HORIZON programme, BY-COVID project (Grant No. 101046203—BY-COVID). National Institute for Infectious Diseases Lazzaro Spallanzani–IRCCS received financial support from the Italian Ministry of Health grant “Ricerca Corrente”. JP, LF: IMI2-JU grants, resources which are composed of financial contributions from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA [GA: 777365 eTRANSAFE], and the EU H2020 Programme [GA:964537 RISKHUNT3R]; Project 001-P-001647—Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”). AMo, MP and AV acknowledge the support of the European Commission under the INFORE project (H2020-ICT-825070) and the PerMedCoE (H2020-ICT-951773). Contributions by TH and BLP were supported by NIH grant #R35GM119770 to TH. MaGo acknowledges funding from Deutsche Forschungsgemeinschaft (DFG) through grants no. 442326535 (NFDI4Health) and 451265285 (NFDI4Health Task Force COVID-19), from the European Commission through the Horizon 2020 framework program under grant no. 825843 (EU-STANDS4PM) and through the Digital Europe program under grant no. 101083771 (EDITH), as well as from the Klaus Tschira Foundation. AL acknowledges support from the Intramural Research Program of the National Library of Medicine (NLM), National Institutes of Health (NIH)., Peer reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

  • Ostaszewski, Marek
  • Niarakis, Anna
  • Mazein, Alexander
  • Kuperstein, Inna
  • Phair, Robert
  • Montagud, Arnau|||0000-0002-7696-1241
  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Vazquez, Miguel
  • Valencia, Alfonso|||0000-0002-8937-6789
We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort to build an open access, interoperable and computable repository of COVID-19 molecular mechanisms. The COVID-19 Disease Map (C19DMap) is a graphical, interactive representation of disease-relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph-based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS-CoV-2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID-19 or similar pandemics in the long-term perspective., We would like to thank Andjela Tatarovic, architect, and Gina Crovetto, a researcher in the field of cancer, for their help with the design of the top-level view diagrams. We would like to acknowledge the Responsible and Reproducible Research (R3) team of the Luxembourg Centre for Systems Biomedicine for supporting the project and providing necessary communication and data sharing resources. The work presented in this paper was carried out using the ELIXIR Luxembourg tools and services. This study was supported by the Luxembourg National Research Fund (FNR) COVID-19 Fast-Track grant programme, grant COVID-19/2020-1/14715687/CovScreen (E. Glaab); European Commission, INFORE grant H2020-ICT-825070 (A. Montagud, M. Ponce de Leon, M. Vazques and A. Valencia); European Commission, PerMedCoE grant H2020-ICT-951773 (A. Montagud, M. Ponce de Leon, M. Vazques and A. Valencia) the Federal Ministry of Education and Research (BMBF, Germany) and the Baden-Württemberg Ministry of Science, the Excellence Strategy of the German Federal and State Governments (A. Renz); German Center for Infection Research (DZIF), grant no 8020708703 (A. Dräger); The Netherlands Organisation for Health Research and Development (ZonMw), grant no 10430012010015, (M. Kutmon, S. Coort, F. Ehrhart, N. Pham, E.L. Willighagen, C.T. Evelo); H2020 Marie Skłodowska-Curie Actions, grant number 765274 (J. Scheel); National Institutes of Health, USA (NIH), grant number U41 HG003751 (L.D. Stein). The development of Reactome is supported by grants from the US National Institutes of Health (U41 HG003751) and the European Molecular Biology Laboratory., Peer Reviewed, "Article signat per més de 50 autors/es: Marek Ostaszewski, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert Phair, Aurelio Orta-Resendiz, Vidisha Singh, Sara Sadat Aghamiri, Marcio Luis Acencio, Enrico Glaab, Andreas Ruepp, Gisela Fobo, Corinna Montrone, Barbara Brauner, Goar Frishman, Luis Cristóbal Monraz Gómez, Julia Somers, Matti Hoch, Shailendra Kumar Gupta, Julia Scheel, Hanna Borlinghaus, Tobias Czauderna, Falk Schreiber, Arnau Montagud, Miguel Ponce de Leon, Akira Funahashi, Yusuke Hiki, Noriko Hiroi, Takahiro G Yamada, Andreas Dräger, Alina Renz, Muhammad Naveez, Zsolt Bocskei, Francesco Messina, Daniela Börnigen, Liam Fergusson, Marta Conti, Marius Rameil, Vanessa Nakonecnij, Jakob Vanhoefer, Leonard Schmiester, Muying Wang,Emily E Ackerman, Jason E Shoemaker, Jeremy Zucker, Kristie Oxford, Jeremy Teuton, Ebru Kocakaya, Gökçe Yağmur Summak, Kristina Hanspers, Martina Kutmon, Susan Coort, Lars Eijssen, Friederike Ehrhart, Devasahayam Arokia Balaya,Denise Slenter, Marvin Martens, Nhung Pham, Robin Haw, Bijay Jassal, Lisa Matthews, Marija Orlic-Milacic, Andrea Senff Ribeiro, Karen Rothfels, Veronica Shamovsky, Ralf Stephan, Cristoffer Sevilla, Thawfeek Varusai, Jean-Marie Ravel, Rupsha Fraser, Vera Ortseifen, Silvia Marchesi, Piotr Gawron, Ewa Smula, Laurent Heirendt, Venkata Satagopam, Guanming Wu, Anders Riutta, Martin Golebiewski, Stuart Owen51,Carole Goble, Xiaoming Hu, Rupert W Overall, Dieter Maier, Angela Bauch, Benjamin M Gyori, John A Bachman, Carlos Vega, Valentin Grouès, Miguel Vazquez, Pablo Porras, Luana Licata, Marta Iannuccelli, Francesca Sacco57, Anastasia Nesterova, Anton Yuryev, Anita de Waard, Denes Turei, Augustin Luna, Ozgun Babur, Sylvain Soliman, Alberto Valdeolivas, Marina Esteban-Medina, Maria Peña-Chilet, Kinza Rian, Tomáš Helikar, Bhanwar Lal Puniya, Dezso Modos, Agatha Treveil, Marton Olbei, Bertrand De Meulder, Stephane Ballereau, Aurélien Dugourd, Aurélien Naldi, Vincent Noël, Laurence Calzone, Chris Sander, Emek Demir, Tamas Korcsmaros, Tom C Freeman, Franck Augé, Jacques S Beckmann, Jan Hasenauer, Olaf Wolkenhauer, Egon L Wilighagen, Alexander R Pico, Chris T Evelo, Marc E Gillespie, Lincoln D Stein, Henning Hermjakob, Peter D'Eustachio, Julio Saez-Rodriguez, Joaquin Dopazo, Alfonso Valencia, Hiroaki Kitano, Emmanuel Barillot, Charles Auffray, Rudi Balling, Reinhard Schneider "
UPCommons. Portal del coneixement obert de la UPC
Publication Contribución de congreso (ConferenceOutput)

BioFVM-X: an MPI+OpenMP 3-D simulator for biological systems

  • Saxena, Gaurav
  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Montagud, Arnau|||0000-0002-7696-1241
  • Vicente Dorca, David
  • Valencia, Alfonso|||0000-0002-8937-6789
Multi-scale simulations require parallelization to address large-scale problems, such as real-sized tumor simulations. BioFVM is a software package that solves diffusive transport Partial Differential Equations for 3-D biological simulations successfully applied to tissue and cancer biology problems. Currently, BioFVM is only shared-memory parallelized using OpenMP, greatly limiting the execution of large-scale jobs in HPC clusters. We present BioFVM-X: an enhanced version of BioFVM capable of running on multiple nodes. BioFVM-X uses MPI+OpenMP to parallelize the generic core kernels of BioFVM and shows promising scalability in large 3-D problems with several hundreds diffusible substrates and ≈ 0.5 billion voxels. The BioFVM-X source code, examples and documentation, are available under the BSD 3-Clause license at https://gitlab.bsc.es/gsaxena/biofvm_x., The research leading to these results has received funding from EU H2020 Programme under the PerMedCoE project, grant agreement number 951773 and the INFORE project, grant agreement number 825070. The authors would like to thank Paul Macklin and Randy Heiland from Indiana University for their constant support and advice regarding BioFVM., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Simulating SARS-CoV-2 epidemics by region-specific variables and modeling contact tracing app containment

  • Ferrari, Alberto
  • Santus, Enrico
  • Cirillo, Davide|||0000-0003-4982-4716
  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Marino, Nicola
  • Ferreti, Maria Teresa
  • Santuccione Chadha, Antonella
  • Mavridis, Nikolaos
  • Valencia, Alfonso|||0000-0002-8937-6789
Targeted contact-tracing through mobile phone apps has been proposed as an instrument to help contain the spread of COVID-19 and manage the lifting of nation-wide lock-downs currently in place in USA and Europe. However, there is an ongoing debate on its potential efficacy, especially in light of region-specific demographics. We built an expanded SIR model of COVID-19 epidemics that accounts for region-specific population densities, and we used it to test the impact of a contact-tracing app in a number of scenarios. Using demographic and mobility data from Italy and Spain, we used the model to simulate scenarios that vary in baseline contact rates, population densities, and fraction of app users in the population. Our results show that, in support of efficient isolation of symptomatic cases, app-mediated contact-tracing can successfully mitigate the epidemic even with a relatively small fraction of users, and even suppress altogether with a larger fraction of users. However, when regional differences in population density are taken into consideration, the epidemic can be significantly harder to contain in higher density areas, highlighting potential limitations of this intervention in specific contexts. This work corroborates previous results in favor of app-mediated contact-tracing as mitigation measure for COVID-19, and draws attention on the importance of region-specific demographic and mobility factors to achieve maximum efficacy in containment policies., This material is based upon work supported by the European Commission’s Horizon 2020 Program, H2020-ICT-12-2018-2020, “INFORE - Interactive Extreme-Scale Analytics and Forecasting” (ref. 825070). The authors would like to acknowledge the Spanish Ministry of Transport, Mobility and Urban Agenda for assistance and support with mobility data., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Systems Biology at the giga-scale: large multi-scale models of complex, heterogeneous multicellular systems

  • Montagud, Arnau|||0000-0002-7696-1241
  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Valencia, Alfonso|||0000-0002-8937-6789
Agent-based modelling has proven its usefulness in several biomedical projects by explaining and uncovering mechanisms in diseases. Nevertheless, the scenarios addressed in these models usually consider a small number of cells, lack cell-specific characterisation and dynamic interactions and have a simplistic environment description. Tools that enable scalable, real-sized simulations of biological systems that require complex set-ups are needed to have simulations closer to biomedical scenarios that can capture cell-to-cell heterogeneity and system-wide emerging properties. To deliver simulations at the giga-scale (109 cells), different tools have implemented technologies to run in high-performance computing clusters. We hereby review these efforts and detail the main areas of improvement the field needs to focus on to have simulations that are a step closer to having digital twins, This work has been partially supported by the European Commission under the INFORE project (H2020-ICT-825070) and the PerMedCoE project (H2020-ICT-951773)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Patient-specific Boolean models of signalling networks guide personalised treatments

  • Montagud, Arnau|||0000-0002-7696-1241
  • Béal, Jonas
  • Tobalina, Luis
  • Traynard, Pauline
  • Subramanian, Vigneshwari
  • Valencia, Alfonso|||0000-0002-8937-6789
Prostate cancer is the second most occurring cancer in men worldwide. To better understand the mechanisms of tumorigenesis and possible treatment responses, we developed a mathematical model of prostate cancer which considers the major signalling pathways known to be deregulated. We personalised this Boolean model to molecular data to reflect the heterogeneity and specific response to perturbations of cancer patients. 488 prostate samples were used to build patient-specific models and compared to available clinical data. Additionally, eight prostate cell-line-specific models were built to validate our approach with dose-response data of several drugs. The effects of single and combined drugs were tested in these models under different growth conditions. We identified 15 actionable points of interventions in one cell-line-specific model whose inactivation hinders tumorigenesis. To validate these results, we tested nine small molecule inhibitors of five of those putative targets and found a dose-dependent effect on four of them, notably those targeting HSP90 and PI3K. These results highlight the predictive power of our personalised Boolean models and illustrate how they can be used for precision oncology., This work has been partially supported by the European Commission under the PrECISE project (H2020-PHC-668858), the INFORE project (H2020-ICT-825070) and the PerMedCoE (H2020-ICT-951773), Peer Reviewed, "Article signat per 12 autors/es: Arnau Montagud, Jonas Béal, Luis Tobalina, Pauline Traynard, Vigneshwari Subramanian, Bence Szalai, Róbert Alföldi, László Puskás, Alfonso Valencia, Emmanuel Barillot, Julio Saez-Rodriguez, Laurence Calzone"
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

COVID-19 Flow-Maps an open geographic information system on COVID-19 and human mobility for Spain

  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Valle, Javier del
  • Fernández González, Jose María|||0000-0002-4806-5140
  • Bernardo, Marc
  • Cirillo, Davide|||0000-0003-4982-4716
  • Sanchez Valle, Jon
  • Smith, Matthew
  • Capella Gutiérrez, Salvador|||0000-0002-0309-604X
  • Gullón, Tania
  • Valencia, Alfonso|||0000-0002-8937-6789
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has spread all over the world leading to a global pandemic. The fast progression of COVID-19 has been mainly related to the high contagion rate of the virus and the worldwide mobility of humans. In the absence of pharmacological therapies, governments from different countries have introduced several non-pharmaceutical interventions to reduce human mobility and social contact. Several studies based on Anonymized Mobile Phone Data have been published analysing the relationship between human mobility and the spread of coronavirus. However, to our knowledge, none of these data-sets integrates cross-referenced geo-localised data on human mobility and COVID-19 cases into one all-inclusive open resource. Herein we present COVID-19 Flow-Maps, a cross-referenced Geographic Information System that integrates regularly updated time-series accounting for population mobility and daily reports of COVID-19 cases in Spain at different scales of time spatial resolution. This integrated and up-to-date data-set can be used to analyse the human dynamics to guide and support the design of more effective non-pharmaceutical interventions., This work was supported by the Generalitat de Catalunya through the project PDAD14/20/00001, and by the H2020 programme under Grant Agreement 825070 (INFORE) and the INB Grant (PT17/0009/0001 - ISCIII-SGEFI/ERDF)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Optimizing dosage-specific treatments in a multi-Scale model of a tumor growth

  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Montagud, Arnau|||0000-0002-7696-1241
  • Akasiadis, Charilaos
  • Schreiber, Janina
  • Ntiniakou, Thaleia
  • Valencia, Alfonso|||0000-0002-8937-6789
The emergence of cell resistance in cancer treatment is a complex phenomenon that emerges from the interplay of processes that occur at different scales. For instance, molecular mechanisms and population-level dynamics such as competition and cell–cell variability have been described as playing a key role in the emergence and evolution of cell resistances. Multi-scale models are a useful tool for studying biology at very different times and spatial scales, as they can integrate different processes occurring at the molecular, cellular, and intercellular levels. In the present work, we use an extended hybrid multi-scale model of 3T3 fibroblast spheroid to perform a deep exploration of the parameter space of effective treatment strategies based on TNF pulses. To explore the parameter space of effective treatments in different scenarios and conditions, we have developed an HPC-optimized model exploration workflow based on EMEWS. We first studied the effect of the cells’ spatial distribution in the values of the treatment parameters by optimizing the supply strategies in 2D monolayers and 3D spheroids of different sizes. We later study the robustness of the effective treatments when heterogeneous populations of cells are considered. We found that our model exploration workflow can find effective treatments in all the studied conditions. Our results show that cells’ spatial geometry and population variability should be considered when optimizing treatment strategies in order to find robust parameter sets., This research has received funding from the Horizon 2020 INFORE Project, GA n° 825070 and the Horizon 2020 PerMedCoE Project, GA n° 951773., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

  • Santus, Enrico
  • Marino, Nicola
  • Cirillo, Davide|||0000-0003-4982-4716
  • Chersoni, Emmanuele
  • Montagud, Arnau|||0000-0002-7696-1241
  • Santuccione Chadha, Antonella
  • Valencia, Alfonso|||0000-0002-8937-6789
  • Hughes, Kevin
  • Lindvall, Charlotta
Artificial intelligence (AI) technologies can play a key role in preventing, detecting, and monitoring epidemics. In this paper, we provide an overview of the recently published literature on the COVID-19 pandemic in four strategic areas: (1) triage, diagnosis, and risk prediction; (2) drug repurposing and development; (3) pharmacogenomics and vaccines; and (4) mining of the medical literature. We highlight how AI-powered health care can enable public health systems to efficiently handle future outbreaks and improve patient outcomes., We are deeply thankful to the Women’s Brain Project (WBP) (www.womensbrainproject.com), an international organization advocating for women’s brain and mental health through scientific research, debate, and public engagement. The authors would like to thank Maria Teresa Ferretti and Shahnaz Radjy for the helpful comments. DC, AM, and AV have received funding from the European Commission’s Horizon 2020 Program H2020-SC1-DTH-2018-1, “iPC-individualizedPaediatricCure” (ref. 826121), and H2020-ICT-2018-2, “INFORE-Interactive Extreme-Scale Analytics and Forecasting” (ref. 825070)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

PhysiBoSS 2.0: a sustainable integration of stochastic Boolean and agent-based modelling frameworks

  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Montagud, Arnau|||0000-0002-7696-1241
  • Noël, Vincent
  • Meert, Annika
  • Pradas, Gerard
  • Barillot, Emmanuel
  • Calzone, Laurence
  • Valencia, Alfonso|||0000-0002-8937-6789
In systems biology, mathematical models and simulations play a crucial role in understanding complex biological systems. Different modelling frameworks are employed depending on the nature and scales of the system under study. For instance, signalling and regulatory networks can be simulated using Boolean modelling, whereas multicellular systems can be studied using agent-based modelling. Herein, we present PhysiBoSS 2.0, a hybrid agent-based modelling framework that allows simulating signalling and regulatory networks within individual cell agents. PhysiBoSS 2.0 is a redesign and reimplementation of PhysiBoSS 1.0 and was conceived as an add-on that expands the PhysiCell functionalities by enabling the simulation of intracellular cell signalling using MaBoSS while keeping a decoupled, maintainable and model-agnostic design. PhysiBoSS 2.0 also expands the set of functionalities offered to the users, including custom models and cell specifications, mechanistic submodels of substrate internalisation and detailed control over simulation parameters. Together with PhysiBoSS 2.0, we introduce PCTK, a Python package developed for handling and processing simulation outputs, and generating summary plots and 3D renders. PhysiBoSS 2.0 allows studying the interplay between the microenvironment, the signalling pathways that control cellular processes and population dynamics, suitable for modelling cancer. We show different approaches for integrating Boolean networks into multi-scale simulations using strategies to study the drug effects and synergies in models of cancer cell lines and validate them using experimental data. PhysiBoSS 2.0 is open-source and publicly available on GitHub with several repositories of accompanying interoperable tools., The authors thank Paul Macklin and Randy Heiland for their support with the PhysiCell code and discussions. The authors acknowledge the technical expertise and assistance provided by the Spanish Supercomputing Network (Red Española de Supercomputación), as well as the computer resources used: the LaPalma Supercomputer (RES-BCV-2019-2-0008), located at the Instituto de Astrofísica de Canarias, and MareNostrum4 (RES-BCV-2019-2-0013, RES-BCV-2020-3-0016, RES-BCV-2021-2-0020), located at the Barcelona Supercomputing Center. This work has received funding from the Horizon 2020 projects: INFORE (ID: 825070), PerMedCoE (ID: 951773) and CREXDATA (ID: 101092749). This work has received funding from the Horizon 2020 projects INFORE (ID: 825070) and PerMedCoE (ID: 951773) and from the Horizon Europe project CREXDATA (ID: 101092749). This work was funded in part by the French government under the management of Agence Nationale de la Recherche as part of the “Investissements d’avenir” programme, reference ANR-19-P3IA-0001 (PRAIRIE 3IA Institute)., Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Contribución de congreso (ConferenceOutput)

INforE: Interactive cross-platform analytics for everyone

  • Giatrakos, Nikos
  • Arnu, David
  • Bitsakis, Theodoros
  • Deligiannakis, Antonios
  • Garofalakis, Minos
  • Klinkenberg, Ralf
  • Konidaris, Aris
  • Kontaxakis, Antonis
  • Kotidis Kotidis, Yannis
  • Samoladas, Vasilis
  • Simitsis, Alkis
  • Stamatakis, George
  • Temme, Fabian
  • Torok, Mate
  • Yaqub, Edwin
  • Montagud, Arnau|||0000-0002-7696-1241
  • Ponce De Leon, Miguel|||0000-0002-7496-844X
  • Arndt, Holger
  • Burkard, Stefan
We present INforE, a prototype supporting non-expert programmers in performing optimized, cross-platform, streaming analytics at scale. INforE offers: a) a new extension to the RapidMiner Studio for graphical design of Big streaming Data workflows, (b) a novel optimizer to instruct the execution of workflows across Big Data platforms and clusters, (c) a synopses data engine for interactivity at scale via the use of data summaries, (d) a distributed, online data mining and machine learning module. To our knowledge INforE is the first holistic approach in streaming settings. We demonstrate INforE in the fields of life science and financial data analysis., This work has received funding from the EU Horizon 2020 research and innovation program INFORE under grant agreement No 825070, Peer Reviewed
UPCommons. Portal del coneixement obert de la UPC
Publication Artículo científico (JournalArticle)

The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer

  • Armaos, Alexandros
  • Serra, François
  • Nuñez Carpintero, Iker|||0000-0002-2637-5236
  • Seo, Ji-Heui
  • Baca, Sylvan C.
  • Gustincich, Stefano
  • Valencia, Alfonso|||0000-0002-8937-6789
  • Freedman, Matthew L.
  • Cirillo, Davide|||0000-0003-4982-4716
  • Giambartolomei, Claudia
  • Tartaglia, Gian Gaetano
We introduce Promoter-Enhancer-Guided Interaction Networks (PENGUIN), a method for studying protein-protein interaction (PPI) networks within enhancer-promoter interactions. PENGUIN integrates H3K27ac-HiChIP data with tissue-specific PPIs to define enhancer-promoter PPI networks (EPINs). We validated PENGUIN using cancer (LNCaP) and benign (LHSAR) prostate cell lines. Our analysis detected EPIN clusters enriched with the architectural protein CTCF, a regulator of enhancer-promoter interactions. CTCF presence was coupled with the prevalence of prostate cancer (PrCa) single nucleotide polymorphisms (SNPs) within the same EPIN clusters, suggesting functional implications in PrCa. Within the EPINs displaying enrichments in both CTCF and PrCa SNPs, we also show enrichment in oncogenes. We substantiated our identified SNPs through CRISPR/Cas9 knockout and RNAi screens experiments. Here we show that PENGUIN provides insights into the intricate interplay between enhancer-promoter interactions and PPI networks, which are crucial for identifying key genes and potential intervention targets. A dedicated server is available at https://penguin.life.bsc.es/., The authors are grateful to José María Fernández González (Barcelona Supercomputing Center) for the crucial guidance with the PENGUIN web server. They also thank the Biola Javierre’s lab at the Josep Carreras Leukaemia Research Institute for the support, the ‘RNA initiative’ at IIT and all the members of Tartaglia’s lab at CRG, Sapienza and IIT. The research leading to these results has been supported by the European Research Council [RIBOMYLOME_309545 and ASTRA_855923], the H2020 projects [IASIS_727658 and INFORE_825080], and the project ONCOLOGICS (ERA Net Grant 779282, ERAPERMED2020- 036; and Departament de Salut-Generalitat de Catalunya support, SLD040/20/000001). CG has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 754490 – MINDED project. I.N.C. was supported by a grant for pre-doctoral contracts for the training of doctors (Project ID: SEV-2015- 628 0493-18-2) (Grant ID: PRE2018-083662) from the Spanish Ministry for Science, Innovation and Universities. M.L.F. is supported by the National Institute of Health (R01CA262577, R01CA251555), the Claudia Adams Barr Program for Innovative Cancer Research, the Dana-Farber Cancer Institute Presidential Initiatives Fund, the H.L. Snyder Medical Research Foundation, the Cutler Family Fund for Prevention and Early Detection, the Donahue Family Fund, W81XWH-21-1-0339 and W81XWH-22-1-0951 (DoD) and the Movember PCF Challenge Award. S.C.B. is supported by W81XWH-21-1-0358 (DoD), the Damon Runyon Cancer Research Foundation, and a gift from Debbie and Bob First., Peer Reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

COVID-19 Flow-Maps an open geographic information system on COVID-19 and human mobility for Spain

  • Ponce De Leon, Miguel
  • Valle, Javier del
  • Fernández González, Jose María
  • Bernardo, Marc
  • Cirillo, Davide
  • Sanchez Valle, Jon
  • Smith, Matthew
  • Capella Gutiérrez, Salvador
  • Gullón, Tania
  • Valencia, Alfonso
COVID-19 is an infectious disease caused by the SARS-CoV-2 virus, which has spread all over the world leading to a global pandemic. The fast progression of COVID-19 has been mainly related to the high contagion rate of the virus and the worldwide mobility of humans. In the absence of pharmacological therapies, governments from different countries have introduced several non-pharmaceutical interventions to reduce human mobility and social contact. Several studies based on Anonymized Mobile Phone Data have been published analysing the relationship between human mobility and the spread of coronavirus. However, to our knowledge, none of these data-sets integrates cross-referenced geo-localised data on human mobility and COVID-19 cases into one all-inclusive open resource. Herein we present COVID-19 Flow-Maps, a cross-referenced Geographic Information System that integrates regularly updated time-series accounting for population mobility and daily reports of COVID-19 cases in Spain at different scales of time spatial resolution. This integrated and up-to-date data-set can be used to analyse the human dynamics to guide and support the design of more effective non-pharmaceutical interventions., This work was supported by the Generalitat de Catalunya through the project PDAD14/20/00001, and by the H2020 programme under Grant Agreement 825070 (INFORE) and the INB Grant (PT17/0009/0001 - ISCIII-SGEFI/ERDF)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

COVID19 Disease Map, a computational knowledge repository of virus–host interaction mechanisms

  • Ostaszewski, Marek
  • Niarakis, Anna
  • Mazein, Alexander
  • Kuperstein, Inna
  • Phair, Robert
  • Montagud, Arnau
  • Ponce De Leon, Miguel
  • Vazquez, Miguel
  • Valencia, Alfonso
We need to effectively combine the knowledge from surging literature with complex datasets to propose mechanistic models of SARS-CoV-2 infection, improving data interpretation and predicting key targets of intervention. Here, we describe a large-scale community effort to build an open access, interoperable and computable repository of COVID-19 molecular mechanisms. The COVID-19 Disease Map (C19DMap) is a graphical, interactive representation of disease-relevant molecular mechanisms linking many knowledge sources. Notably, it is a computational resource for graph-based analyses and disease modelling. To this end, we established a framework of tools, platforms and guidelines necessary for a multifaceted community of biocurators, domain experts, bioinformaticians and computational biologists. The diagrams of the C19DMap, curated from the literature, are integrated with relevant interaction and text mining databases. We demonstrate the application of network analysis and modelling approaches by concrete examples to highlight new testable hypotheses. This framework helps to find signatures of SARS-CoV-2 predisposition, treatment response or prioritisation of drug candidates. Such an approach may help deal with new waves of COVID-19 or similar pandemics in the long-term perspective., We would like to thank Andjela Tatarovic, architect, and Gina Crovetto, a researcher in the field of cancer, for their help with the design of the top-level view diagrams. We would like to acknowledge the Responsible and Reproducible Research (R3) team of the Luxembourg Centre for Systems Biomedicine for supporting the project and providing necessary communication and data sharing resources. The work presented in this paper was carried out using the ELIXIR Luxembourg tools and services. This study was supported by the Luxembourg National Research Fund (FNR) COVID-19 Fast-Track grant programme, grant COVID-19/2020-1/14715687/CovScreen (E. Glaab); European Commission, INFORE grant H2020-ICT-825070 (A. Montagud, M. Ponce de Leon, M. Vazques and A. Valencia); European Commission, PerMedCoE grant H2020-ICT-951773 (A. Montagud, M. Ponce de Leon, M. Vazques and A. Valencia) the Federal Ministry of Education and Research (BMBF, Germany) and the Baden-Württemberg Ministry of Science, the Excellence Strategy of the German Federal and State Governments (A. Renz); German Center for Infection Research (DZIF), grant no 8020708703 (A. Dräger); The Netherlands Organisation for Health Research and Development (ZonMw), grant no 10430012010015, (M. Kutmon, S. Coort, F. Ehrhart, N. Pham, E.L. Willighagen, C.T. Evelo); H2020 Marie Skłodowska-Curie Actions, grant number 765274 (J. Scheel); National Institutes of Health, USA (NIH), grant number U41 HG003751 (L.D. Stein). The development of Reactome is supported by grants from the US National Institutes of Health (U41 HG003751) and the European Molecular Biology Laboratory., Peer Reviewed, "Article signat per més de 50 autors/es: Marek Ostaszewski, Anna Niarakis, Alexander Mazein, Inna Kuperstein, Robert Phair, Aurelio Orta-Resendiz, Vidisha Singh, Sara Sadat Aghamiri, Marcio Luis Acencio, Enrico Glaab, Andreas Ruepp, Gisela Fobo, Corinna Montrone, Barbara Brauner, Goar Frishman, Luis Cristóbal Monraz Gómez, Julia Somers, Matti Hoch, Shailendra Kumar Gupta, Julia Scheel, Hanna Borlinghaus, Tobias Czauderna, Falk Schreiber, Arnau Montagud, Miguel Ponce de Leon, Akira Funahashi, Yusuke Hiki, Noriko Hiroi, Takahiro G Yamada, Andreas Dräger, Alina Renz, Muhammad Naveez, Zsolt Bocskei, Francesco Messina, Daniela Börnigen, Liam Fergusson, Marta Conti, Marius Rameil, Vanessa Nakonecnij, Jakob Vanhoefer, Leonard Schmiester, Muying Wang,Emily E Ackerman, Jason E Shoemaker, Jeremy Zucker, Kristie Oxford, Jeremy Teuton, Ebru Kocakaya, Gökçe Yağmur Summak, Kristina Hanspers, Martina Kutmon, Susan Coort, Lars Eijssen, Friederike Ehrhart, Devasahayam Arokia Balaya,Denise Slenter, Marvin Martens, Nhung Pham, Robin Haw, Bijay Jassal, Lisa Matthews, Marija Orlic-Milacic, Andrea Senff Ribeiro, Karen Rothfels, Veronica Shamovsky, Ralf Stephan, Cristoffer Sevilla, Thawfeek Varusai, Jean-Marie Ravel, Rupsha Fraser, Vera Ortseifen, Silvia Marchesi, Piotr Gawron, Ewa Smula, Laurent Heirendt, Venkata Satagopam, Guanming Wu, Anders Riutta, Martin Golebiewski, Stuart Owen51,Carole Goble, Xiaoming Hu, Rupert W Overall, Dieter Maier, Angela Bauch, Benjamin M Gyori, John A Bachman, Carlos Vega, Valentin Grouès, Miguel Vazquez, Pablo Porras, Luana Licata, Marta Iannuccelli, Francesca Sacco57, Anastasia Nesterova, Anton Yuryev, Anita de Waard, Denes Turei, Augustin Luna, Ozgun Babur, Sylvain Soliman, Alberto Valdeolivas, Marina Esteban-Medina, Maria Peña-Chilet, Kinza Rian, Tomáš Helikar, Bhanwar Lal Puniya, Dezso Modos, Agatha Treveil, Marton Olbei, Bertrand De Meulder, Stephane Ballereau, Aurélien Dugourd, Aurélien Naldi, Vincent Noël, Laurence Calzone, Chris Sander, Emek Demir, Tamas Korcsmaros, Tom C Freeman, Franck Augé, Jacques S Beckmann, Jan Hasenauer, Olaf Wolkenhauer, Egon L Wilighagen, Alexander R Pico, Chris T Evelo, Marc E Gillespie, Lincoln D Stein, Henning Hermjakob, Peter D'Eustachio, Julio Saez-Rodriguez, Joaquin Dopazo, Alfonso Valencia, Hiroaki Kitano, Emmanuel Barillot, Charles Auffray, Rudi Balling, Reinhard Schneider ", Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The PENGUIN approach to reconstruct protein interactions at enhancer-promoter regions and its application to prostate cancer

  • Armaos, Alexandros
  • Serra, François
  • Nuñez Carpintero, Iker
  • Seo, Ji-Heui
  • Baca, Sylvan C.
  • Gustincich, Stefano
  • Valencia, Alfonso
  • Freedman, Matthew L.
  • Cirillo, Davide
  • Giambartolomei, Claudia
  • Tartaglia, Gian Gaetano
We introduce Promoter-Enhancer-Guided Interaction Networks (PENGUIN), a method for studying protein-protein interaction (PPI) networks within enhancer-promoter interactions. PENGUIN integrates H3K27ac-HiChIP data with tissue-specific PPIs to define enhancer-promoter PPI networks (EPINs). We validated PENGUIN using cancer (LNCaP) and benign (LHSAR) prostate cell lines. Our analysis detected EPIN clusters enriched with the architectural protein CTCF, a regulator of enhancer-promoter interactions. CTCF presence was coupled with the prevalence of prostate cancer (PrCa) single nucleotide polymorphisms (SNPs) within the same EPIN clusters, suggesting functional implications in PrCa. Within the EPINs displaying enrichments in both CTCF and PrCa SNPs, we also show enrichment in oncogenes. We substantiated our identified SNPs through CRISPR/Cas9 knockout and RNAi screens experiments. Here we show that PENGUIN provides insights into the intricate interplay between enhancer-promoter interactions and PPI networks, which are crucial for identifying key genes and potential intervention targets. A dedicated server is available at https://penguin.life.bsc.es/., The authors are grateful to José María Fernández González (Barcelona Supercomputing Center) for the crucial guidance with the PENGUIN web server. They also thank the Biola Javierre’s lab at the Josep Carreras Leukaemia Research Institute for the support, the ‘RNA initiative’ at IIT and all the members of Tartaglia’s lab at CRG, Sapienza and IIT. The research leading to these results has been supported by the European Research Council [RIBOMYLOME_309545 and ASTRA_855923], the H2020 projects [IASIS_727658 and INFORE_825080], and the project ONCOLOGICS (ERA Net Grant 779282, ERAPERMED2020- 036; and Departament de Salut-Generalitat de Catalunya support, SLD040/20/000001). CG has received funding from the European Union’s Horizon 2020 research and innovation programme under the Marie Skłodowska-Curie grant agreement No 754490 – MINDED project. I.N.C. was supported by a grant for pre-doctoral contracts for the training of doctors (Project ID: SEV-2015- 628 0493-18-2) (Grant ID: PRE2018-083662) from the Spanish Ministry for Science, Innovation and Universities. M.L.F. is supported by the National Institute of Health (R01CA262577, R01CA251555), the Claudia Adams Barr Program for Innovative Cancer Research, the Dana-Farber Cancer Institute Presidential Initiatives Fund, the H.L. Snyder Medical Research Foundation, the Cutler Family Fund for Prevention and Early Detection, the Donahue Family Fund, W81XWH-21-1-0339 and W81XWH-22-1-0951 (DoD) and the Movember PCF Challenge Award. S.C.B. is supported by W81XWH-21-1-0358 (DoD), the Damon Runyon Cancer Research Foundation, and a gift from Debbie and Bob First., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Systems Biology at the giga-scale: large multi-scale models of complex, heterogeneous multicellular systems

  • Montagud, Arnau
  • Ponce De Leon, Miguel
  • Valencia, Alfonso
Agent-based modelling has proven its usefulness in several biomedical projects by explaining and uncovering mechanisms in diseases. Nevertheless, the scenarios addressed in these models usually consider a small number of cells, lack cell-specific characterisation and dynamic interactions and have a simplistic environment description. Tools that enable scalable, real-sized simulations of biological systems that require complex set-ups are needed to have simulations closer to biomedical scenarios that can capture cell-to-cell heterogeneity and system-wide emerging properties. To deliver simulations at the giga-scale (109 cells), different tools have implemented technologies to run in high-performance computing clusters. We hereby review these efforts and detail the main areas of improvement the field needs to focus on to have simulations that are a step closer to having digital twins, This work has been partially supported by the European Commission under the INFORE project (H2020-ICT-825070) and the PerMedCoE project (H2020-ICT-951773)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CROSSalive: a web server for predicting the in vivo structure of RNA molecules

  • Delli Ponti, Riccardo, 1987-
  • Armaos, Alexandros, 1989-
  • Vandelli, Andrea
  • Tartaglia, Gian Gaetano
MOTIVATION: RNA structure is difficult to predict in vivo due to interactions with enzymes and other molecules. Here we introduce CROSSalive, an algorithm to predict the single- and double-stranded regions of RNAs in vivo using predictions of protein interactions. RESULTS: Trained on icSHAPE data in presence (m6a+) and absence of N6 methyladenosine modification (m6a-), CROSSalive achieves cross-validation accuracies between 0.70 and 0.88 in identifying high-confidence single- and double-stranded regions. The algorithm was applied to the long non-coding RNA Xist (17 900 nt, not present in the training) and shows an Area under the ROC curve of 0.83 in predicting structured regions. AVAILABILITY AND IMPLEMENTATION: CROSSalive webserver is freely accessible at http://service.tartaglialab.com/new_submission/crossalive. SUPPLEMENTARY INFORMATION: Supplementary data are available at Bioinformatics online., The research leading to these results has received funding from European Research Council RIBOMYLOME_309545, European Union's Horizon 2020 IASIS_727658 and INFORE_825070, as well as Spanish Ministry of Economy and Competitiveness BFU2017-86970-P
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Long non-coding RNA-polycomb intimate rendezvous

  • Cerase, Andrea
  • Tartaglia, Gian Gaetano
The interaction between polycomb-repressive complexes 1/2 (PRC1/2) and long non-coding RNA (lncRNA), such as the X inactive specific transcript Xist and the HOX transcript antisense RNA (HOTAIR), has been the subject of intense debate. While cross-linking, immuno-precipitation and super-resolution microscopy argue against direct interaction of Polycomb with some lncRNAs, there is increasing evidence supporting the ability of both PRC1 and PRC2 to functionally associate with RNA. Recent data indicate that these interactions are in most cases spurious, but nonetheless crucial for a number of cellular activities. In this review, we suggest that while PRC1/2 recruitment by HOTAIR might be direct, in the case of Xist, it might occur indirectly and, at least in part, through the process of liquid-liquid phase separation. We present recent models of lncRNA-mediated PRC1/2 recruitment to their targets and describe potential RNA-mediated roles in the three-dimensional organization of the nucleus., A.C. had been funded by a Rett Syndrome Research Trust (RSRT) and a BARTS Charity grants and by QMUL intramural support. The research leading to these results has been supported by European Research Council (RIBOMYLOME 309545 and ASTRA 855923), the Spanish Ministry of Economy and Competitiveness (BFU2017-86970-P) and H2020 projects (IASIS 727658 and INFORE 825080).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Simulating SARS-CoV-2 epidemics by region-specific variables and modeling contact tracing app containment

  • Ferrari, Alberto
  • Santus, Enrico
  • Cirillo, Davide
  • Ponce De Leon, Miguel
  • Marino, Nicola
  • Ferreti, Maria Teresa
  • Santuccione Chadha, Antonella
  • Mavridis, Nikolaos
  • Valencia, Alfonso
Targeted contact-tracing through mobile phone apps has been proposed as an instrument to help contain the spread of COVID-19 and manage the lifting of nation-wide lock-downs currently in place in USA and Europe. However, there is an ongoing debate on its potential efficacy, especially in light of region-specific demographics. We built an expanded SIR model of COVID-19 epidemics that accounts for region-specific population densities, and we used it to test the impact of a contact-tracing app in a number of scenarios. Using demographic and mobility data from Italy and Spain, we used the model to simulate scenarios that vary in baseline contact rates, population densities, and fraction of app users in the population. Our results show that, in support of efficient isolation of symptomatic cases, app-mediated contact-tracing can successfully mitigate the epidemic even with a relatively small fraction of users, and even suppress altogether with a larger fraction of users. However, when regional differences in population density are taken into consideration, the epidemic can be significantly harder to contain in higher density areas, highlighting potential limitations of this intervention in specific contexts. This work corroborates previous results in favor of app-mediated contact-tracing as mitigation measure for COVID-19, and draws attention on the importance of region-specific demographic and mobility factors to achieve maximum efficacy in containment policies., This material is based upon work supported by the European Commission’s Horizon 2020 Program, H2020-ICT-12-2018-2020, “INFORE - Interactive Extreme-Scale Analytics and Forecasting” (ref. 825070). The authors would like to acknowledge the Spanish Ministry of Transport, Mobility and Urban Agenda for assistance and support with mobility data., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

RNA-binding and prion domains: the Yin and Yang of phase separation

  • Lorenzo Gotor, Maria de las Nieves
  • Armaos, Alexandros, 1989-
  • Calloni, Giulia
  • Torrent Burgas, Marc
  • Vabulas, R. Martin
  • Sánchez de Groot, Natalia
  • Tartaglia, Gian Gaetano
Proteins and RNAs assemble in membrane-less organelles that organize intracellular spaces and regulate biochemical reactions. The ability of proteins and RNAs to form condensates is encoded in their sequences, yet it is unknown which domains drive the phase separation (PS) process and what are their specific roles. Here, we systematically investigated the human and yeast proteomes to find regions promoting condensation. Using advanced computational methods to predict the PS propensity of proteins, we designed a set of experiments to investigate the contributions of Prion-Like Domains (PrLDs) and RNA-binding domains (RBDs). We found that one PrLD is sufficient to drive PS, whereas multiple RBDs are needed to modulate the dynamics of the assemblies. In the case of stress granule protein Pub1 we show that the PrLD promotes sequestration of protein partners and the RBD confers liquid-like behaviour to the condensate. Our work sheds light on the fine interplay between RBDs and PrLD to regulate formation of membrane-less organelles, opening up the avenue for their manipulation., European Research Council (ERC) [RIBOMYLOME_309545 to G.G.T., ASTRA_855923 to G.G.T., METAMETA_311522 to R.M.V.]; Spanish Ministry of Economy and Competitiveness [BFU2014-55054-P, BFU2017-86970-P]; H2020 Projects [IASIS_727658, INFORE_825080]; ‘Centro de Excelencia Severo Ochoa 2013-2017’; CERCA Programme/Generalitat de Catalunya (to EMBL partnership); Spanish Ministry for Science and Competitiveness (MINECO) (to EMBL partnership). Funding for open access charge: ERC [855923].
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Optimizing dosage-specific treatments in a multi-Scale model of a tumor growth

  • Ponce De Leon, Miguel
  • Montagud, Arnau
  • Akasiadis, Charilaos
  • Schreiber, Janina
  • Ntiniakou, Thaleia
  • Valencia, Alfonso
The emergence of cell resistance in cancer treatment is a complex phenomenon that emerges from the interplay of processes that occur at different scales. For instance, molecular mechanisms and population-level dynamics such as competition and cell–cell variability have been described as playing a key role in the emergence and evolution of cell resistances. Multi-scale models are a useful tool for studying biology at very different times and spatial scales, as they can integrate different processes occurring at the molecular, cellular, and intercellular levels. In the present work, we use an extended hybrid multi-scale model of 3T3 fibroblast spheroid to perform a deep exploration of the parameter space of effective treatment strategies based on TNF pulses. To explore the parameter space of effective treatments in different scenarios and conditions, we have developed an HPC-optimized model exploration workflow based on EMEWS. We first studied the effect of the cells’ spatial distribution in the values of the treatment parameters by optimizing the supply strategies in 2D monolayers and 3D spheroids of different sizes. We later study the robustness of the effective treatments when heterogeneous populations of cells are considered. We found that our model exploration workflow can find effective treatments in all the studied conditions. Our results show that cells’ spatial geometry and population variability should be considered when optimizing treatment strategies in order to find robust parameter sets., This research has received funding from the Horizon 2020 INFORE Project, GA n° 825070 and the Horizon 2020 PerMedCoE Project, GA n° 951773., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Contribución de congreso (ConferenceOutput)

BioFVM-X: an MPI+OpenMP 3-D simulator for biological systems

  • Saxena, Gaurav
  • Ponce De Leon, Miguel
  • Montagud, Arnau
  • Vicente Dorca, David
  • Valencia, Alfonso
Multi-scale simulations require parallelization to address large-scale problems, such as real-sized tumor simulations. BioFVM is a software package that solves diffusive transport Partial Differential Equations for 3-D biological simulations successfully applied to tissue and cancer biology problems. Currently, BioFVM is only shared-memory parallelized using OpenMP, greatly limiting the execution of large-scale jobs in HPC clusters. We present BioFVM-X: an enhanced version of BioFVM capable of running on multiple nodes. BioFVM-X uses MPI+OpenMP to parallelize the generic core kernels of BioFVM and shows promising scalability in large 3-D problems with several hundreds diffusible substrates and ≈ 0.5 billion voxels. The BioFVM-X source code, examples and documentation, are available under the BSD 3-Clause license at https://gitlab.bsc.es/gsaxena/biofvm_x., The research leading to these results has received funding from EU H2020 Programme under the PerMedCoE project, grant agreement number 951773 and the INFORE project, grant agreement number 825070. The authors would like to thank Paul Macklin and Randy Heiland from Indiana University for their constant support and advice regarding BioFVM., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Contribución de congreso (ConferenceOutput)

INforE: Interactive cross-platform analytics for everyone

  • Giatrakos, Nikos
  • Arnu, David
  • Bitsakis, Theodoros
  • Deligiannakis, Antonios
  • Garofalakis, Minos
  • Klinkenberg, Ralf
  • Konidaris, Aris
  • Kontaxakis, Antonis
  • Kotidis Kotidis, Yannis
  • Samoladas, Vasilis
  • Simitsis, Alkis
  • Stamatakis, George
  • Temme, Fabian
  • Torok, Mate
  • Yaqub, Edwin
  • Montagud, Arnau
  • Ponce De Leon, Miguel
  • Arndt, Holger
  • Burkard, Stefan
We present INforE, a prototype supporting non-expert programmers in performing optimized, cross-platform, streaming analytics at scale. INforE offers: a) a new extension to the RapidMiner Studio for graphical design of Big streaming Data workflows, (b) a novel optimizer to instruct the execution of workflows across Big Data platforms and clusters, (c) a synopses data engine for interactivity at scale via the use of data summaries, (d) a distributed, online data mining and machine learning module. To our knowledge INforE is the first holistic approach in streaming settings. We demonstrate INforE in the fields of life science and financial data analysis., This work has received funding from the EU Horizon 2020 research and innovation program INFORE under grant agreement No 825070, Peer Reviewed, Postprint (author's final draft)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Drug-target identification in COVID-19 disease mechanisms using computational systems biology approaches

  • Niarakis, Anna
  • Piñero González, Janet, 1977-
  • Furlong, Laura I., 1971-
  • COVID-19 Disease Map Community
Introduction: The COVID-19 Disease Map project is a large-scale community effort uniting 277 scientists from 130 Institutions around the globe. We use high-quality, mechanistic content describing SARS-CoV-2-host interactions and develop interoperable bioinformatic pipelines for novel target identification and drug repurposing. Methods: Extensive community work allowed an impressive step forward in building interfaces between Systems Biology tools and platforms. Our framework can link biomolecules from omics data analysis and computational modelling to dysregulated pathways in a cell-, tissue- or patient-specific manner. Drug repurposing using text mining and AI-assisted analysis identified potential drugs, chemicals and microRNAs that could target the identified key factors. Results: Results revealed drugs already tested for anti-COVID-19 efficacy, providing a mechanistic context for their mode of action, and drugs already in clinical trials for treating other diseases, never tested against COVID-19. Discussion: The key advance is that the proposed framework is versatile and expandable, offering a significant upgrade in the arsenal for virus-host interactions and other complex pathologies., The author(s) declare financial support was received for the research, authorship, and/or publication of this article. AN acknowledges support from SANOFI-AVENTIS R&D via the CIFRE contract, n° 2020/0766. MK, FH, NP, FE, and CE acknowledge the support of the ZonMw COVID-19 programme (Grant No. 10430012010015). JD Spanish Ministry of Science and Innovation (Grant no. PID2020-117979RB-I00) and Instituto de Salud Carlos III (Grant no. IMP/00019). MAi, KK, FS: Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 251654672 - TRR 161 and under Germany’s Excellence Strategy - EXC 2117 - 422037984. FM: “5 per 1000–2021” grant of the Italian Ministry of Health (Grant No. 5M-2021-23683787) and European Commission with HORIZON programme, BY-COVID project (Grant No. 101046203—BY-COVID). National Institute for Infectious Diseases Lazzaro Spallanzani–IRCCS received financial support from the Italian Ministry of Health grant “Ricerca Corrente”. JP, LF: IMI2-JU grants, resources which are composed of financial contributions from the European Union’s Horizon 2020 Research and Innovation Programme and EFPIA [GA: 777365 eTRANSAFE], and the EU H2020 Programme [GA:964537 RISKHUNT3R]; Project 001-P-001647—Valorisation of EGA for Industry and Society funded by the European Regional Development Fund (ERDF) and Generalitat de Catalunya; Institute of Health Carlos III (project IMPaCT-Data, exp. IMP/00019), co-funded by the European Union, European Regional Development Fund (ERDF, “A way to make Europe”). AMo, MP and AV acknowledge the support of the European Commission under the INFORE project (H2020-ICT-825070) and the PerMedCoE (H2020-ICT-951773). Contributions by TH and BLP were supported by NIH grant #R35GM119770 to TH. MaGo acknowledges funding from Deutsche Forschungsgemeinschaft (DFG) through grants no. 442326535 (NFDI4Health) and 451265285 (NFDI4Health Task Force COVID-19), from the European Commission through the Horizon 2020 framework program under grant no. 825843 (EU-STANDS4PM) and through the Digital Europe program under grant no. 101083771 (EDITH), as well as from the Klaus Tschira Foundation. AL acknowledges support from the Intramural Research Program of the National Library of Medicine (NLM), National Institutes of Health (NIH).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

PhysiBoSS 2.0: a sustainable integration of stochastic Boolean and agent-based modelling frameworks

  • Ponce De Leon, Miguel
  • Montagud, Arnau
  • Noël, Vincent
  • Meert, Annika
  • Pradas, Gerard
  • Barillot, Emmanuel
  • Calzone, Laurence
  • Valencia, Alfonso
In systems biology, mathematical models and simulations play a crucial role in understanding complex biological systems. Different modelling frameworks are employed depending on the nature and scales of the system under study. For instance, signalling and regulatory networks can be simulated using Boolean modelling, whereas multicellular systems can be studied using agent-based modelling. Herein, we present PhysiBoSS 2.0, a hybrid agent-based modelling framework that allows simulating signalling and regulatory networks within individual cell agents. PhysiBoSS 2.0 is a redesign and reimplementation of PhysiBoSS 1.0 and was conceived as an add-on that expands the PhysiCell functionalities by enabling the simulation of intracellular cell signalling using MaBoSS while keeping a decoupled, maintainable and model-agnostic design. PhysiBoSS 2.0 also expands the set of functionalities offered to the users, including custom models and cell specifications, mechanistic submodels of substrate internalisation and detailed control over simulation parameters. Together with PhysiBoSS 2.0, we introduce PCTK, a Python package developed for handling and processing simulation outputs, and generating summary plots and 3D renders. PhysiBoSS 2.0 allows studying the interplay between the microenvironment, the signalling pathways that control cellular processes and population dynamics, suitable for modelling cancer. We show different approaches for integrating Boolean networks into multi-scale simulations using strategies to study the drug effects and synergies in models of cancer cell lines and validate them using experimental data. PhysiBoSS 2.0 is open-source and publicly available on GitHub with several repositories of accompanying interoperable tools., The authors thank Paul Macklin and Randy Heiland for their support with the PhysiCell code and discussions. The authors acknowledge the technical expertise and assistance provided by the Spanish Supercomputing Network (Red Española de Supercomputación), as well as the computer resources used: the LaPalma Supercomputer (RES-BCV-2019-2-0008), located at the Instituto de Astrofísica de Canarias, and MareNostrum4 (RES-BCV-2019-2-0013, RES-BCV-2020-3-0016, RES-BCV-2021-2-0020), located at the Barcelona Supercomputing Center. This work has received funding from the Horizon 2020 projects: INFORE (ID: 825070), PerMedCoE (ID: 951773) and CREXDATA (ID: 101092749). This work has received funding from the Horizon 2020 projects INFORE (ID: 825070) and PerMedCoE (ID: 951773) and from the Horizon Europe project CREXDATA (ID: 101092749). This work was funded in part by the French government under the management of Agence Nationale de la Recherche as part of the “Investissements d’avenir” programme, reference ANR-19-P3IA-0001 (PRAIRIE 3IA Institute)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Artificial Intelligence–Aided Precision Medicine for COVID-19: Strategic Areas of Research and Development

  • Santus, Enrico
  • Marino, Nicola
  • Cirillo, Davide
  • Chersoni, Emmanuele
  • Montagud, Arnau
  • Santuccione Chadha, Antonella
  • Valencia, Alfonso
  • Hughes, Kevin
  • Lindvall, Charlotta
Artificial intelligence (AI) technologies can play a key role in preventing, detecting, and monitoring epidemics. In this paper, we provide an overview of the recently published literature on the COVID-19 pandemic in four strategic areas: (1) triage, diagnosis, and risk prediction; (2) drug repurposing and development; (3) pharmacogenomics and vaccines; and (4) mining of the medical literature. We highlight how AI-powered health care can enable public health systems to efficiently handle future outbreaks and improve patient outcomes., We are deeply thankful to the Women’s Brain Project (WBP) (www.womensbrainproject.com), an international organization advocating for women’s brain and mental health through scientific research, debate, and public engagement. The authors would like to thank Maria Teresa Ferretti and Shahnaz Radjy for the helpful comments. DC, AM, and AV have received funding from the European Commission’s Horizon 2020 Program H2020-SC1-DTH-2018-1, “iPC-individualizedPaediatricCure” (ref. 826121), and H2020-ICT-2018-2, “INFORE-Interactive Extreme-Scale Analytics and Forecasting” (ref. 825070)., Peer Reviewed, Postprint (published version)
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Identification of long non-coding RNAs and RNA binding proteins in breast cancer subtypes

  • Cava, Claudia
  • Armaos, Alexandros, 1989-
  • Lang, Benjamin
  • Tartaglia, Gian Gaetano
  • Castiglioni, Isabella
Breast cancer is a heterogeneous disease classified into four main subtypes with different clinical outcomes, such as patient survival, prognosis, and relapse. Current genetic tests for the differential diagnosis of BC subtypes showed a poor reproducibility. Therefore, an early and correct diagnosis of molecular subtypes is one of the challenges in the clinic. In the present study, we identified differentially expressed genes, long non-coding RNAs and RNA binding proteins for each BC subtype from a public dataset applying bioinformatics algorithms. In addition, we investigated their interactions and we proposed interacting biomarkers as potential signature specific for each BC subtype. We found a network of only 2 RBPs (RBM20 and PCDH20) and 2 genes (HOXB3 and RASSF7) for luminal A, a network of 21 RBPs and 53 genes for luminal B, a HER2-specific network of 14 RBPs and 30 genes, and a network of 54 RBPs and 302 genes for basal BC. We validated the signature considering their expression levels on an independent dataset evaluating their ability to classify the different molecular subtypes with a machine learning approach. Overall, we achieved good performances of classification with an accuracy >0.80. In addition, we found some interesting novel prognostic biomarkers such as RASSF7 for luminal A, DCTPP1 for luminal B, DHRS11, KLC3, NAGS, and TMEM98 for HER2, and ABHD14A and ADSSL1 for basal. The findings could provide preliminary evidence to identify putative new prognostic biomarkers and therapeutic targets for individual breast cancer subtypes., The research leading to these results has been supported by European Research Council grant agreements RIBOMYLOME (309545) and ASTRA (855923), and the European Union’s Horizon 2020 research and innovation programme grant agreements IASIS (727658), DeepRNA (793135), and INFORE (825080). We would like to thank for the financial support the project Grant SysBioNet, Italian Roadmap Research Infrastructures 2012.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The interplay between disordered regions in RNAs and proteins modulates interactions within stress granules and processing bodies

  • Vandelli, Andrea
  • Cid Samper, Fernando, 1991-
  • Torrent Burgas, Marc
  • Sánchez de Groot, Natalia
  • Tartaglia, Gian Gaetano
Condensation, or liquid-like phase separation, is a phenomenon indispensable for the spatiotemporal regulation of molecules within the cell. Recent studies indicate that the composition and molecular organization of phase-separated organelles such as Stress Granules (SGs) and Processing Bodies (PBs) are highly variable and dynamic. A dense contact network involving both RNAs and proteins controls the formation of SGs and PBs and an intricate molecular architecture, at present poorly understood, guarantees that these assemblies sense and adapt to different stresses and environmental changes. Here, we investigated the physico-chemical properties of SGs and PBs components and studied the architecture of their interaction networks. We found that proteins and RNAs establishing the largest amount of contacts in SGs and PBs have distinct properties and intrinsic disorder is enriched in all protein-RNA, protein-protein and RNA-RNA interaction networks. The increase of disorder in proteins is accompanied by an enrichment in single-stranded regions of RNA binding partners. Our results suggest that SGs and PBs quickly assemble and disassemble through dynamic contacts modulated by unfolded domains of their components., The research leading to these results has been supported by European Research Council [RIBOMYLOME_309545 and ASTRA_855923], the H2020 projects [IASIS_727658 and INFORE_825080] and the Spanish Ministry of Science and Innovation (RYC2019-026752-I and PID2020-117454RA-I00).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Structural analysis of SARS-CoV-2 genome and predictions of the human interactome

  • Vandelli, Andrea
  • Monti, Michele
  • Milanetti, Edoardo
  • Armaos, Alexandros, 1989-
  • Rupert, Jakob
  • Zacco, Elsa
  • Bechara, Elias
  • Delli Ponti, Riccardo, 1987-
  • Tartaglia, Gian Gaetano
Specific elements of viral genomes regulate interactions within host cells. Here, we calculated the secondary structure content of >2000 coronaviruses and computed >100 000 human protein interactions with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The genomic regions display different degrees of conservation. SARS-CoV-2 domain encompassing nucleotides 22 500-23 000 is conserved both at the sequence and structural level. The regions upstream and downstream, however, vary significantly. This part of the viral sequence codes for the Spike S protein that interacts with the human receptor angiotensin-converting enzyme 2 (ACE2). Thus, variability of Spike S is connected to different levels of viral entry in human cells within the population. Our predictions indicate that the 5' end of SARS-CoV-2 is highly structured and interacts with several human proteins. The binding proteins are involved in viral RNA processing, include double-stranded RNA specific editases and ATP-dependent RNA-helicases and have strong propensity to form stress granules and phase-separated assemblies. We propose that these proteins, also implicated in viral infections such as HIV, are selectively recruited by SARS-CoV-2 genome to alter transcriptional and post-transcriptional regulation of host cells and to promote viral replication., European Research Council [RIBOMYLOME_309545, ASTRA_855923]; H2020 projects [IASIS_727658 and INFORE_825080]; Spanish Ministry of Economy and Competitiveness [BFU2017-86970-P]; collaboration with Peter St. George-Hyslop financed by the Wellcome Trust. Funding for open access charge: ERC [ASTRA 855923].
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Patient-specific Boolean models of signalling networks guide personalised treatments

  • Montagud, Arnau
  • Béal, Jonas
  • Tobalina, Luis
  • Traynard, Pauline
  • Subramanian, Vigneshwari
  • Valencia, Alfonso
Prostate cancer is the second most occurring cancer in men worldwide. To better understand the mechanisms of tumorigenesis and possible treatment responses, we developed a mathematical model of prostate cancer which considers the major signalling pathways known to be deregulated. We personalised this Boolean model to molecular data to reflect the heterogeneity and specific response to perturbations of cancer patients. 488 prostate samples were used to build patient-specific models and compared to available clinical data. Additionally, eight prostate cell-line-specific models were built to validate our approach with dose-response data of several drugs. The effects of single and combined drugs were tested in these models under different growth conditions. We identified 15 actionable points of interventions in one cell-line-specific model whose inactivation hinders tumorigenesis. To validate these results, we tested nine small molecule inhibitors of five of those putative targets and found a dose-dependent effect on four of them, notably those targeting HSP90 and PI3K. These results highlight the predictive power of our personalised Boolean models and illustrate how they can be used for precision oncology., This work has been partially supported by the European Commission under the PrECISE project (H2020-PHC-668858), the INFORE project (H2020-ICT-825070) and the PerMedCoE (H2020-ICT-951773), Peer Reviewed, "Article signat per 12 autors/es: Arnau Montagud, Jonas Béal, Luis Tobalina, Pauline Traynard, Vigneshwari Subramanian, Bence Szalai, Róbert Alföldi, László Puskás, Alfonso Valencia, Emmanuel Barillot, Julio Saez-Rodriguez, Laurence Calzone", Postprint (author's final draft)
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

RNA-binding and prion domains, the Yin and Yang of phase separation

  • Gotor, Nieves Lorenzo
  • Armaos, Alexandros|||0000-0003-0607-5663
  • Calloni, Giulia
  • Torrent, Marc|||0000-0001-6567-3474
  • Vabulas, R. Martin
  • Sánchez de Groot, Natalia|||0000-0002-0492-5532
  • Tartaglia, Gian Gaetano|||0000-0001-7524-6310
Proteins and RNAs assemble in membrane-less organelles that organize intracellular spaces and regulate biochemical reactions. The ability of proteins and RNAs to form condensates is encoded in their sequences, yet it is unknown which domains drive the phase separation (PS) process and what are their specific roles. Here, we systematically investigated the human and yeast proteomes to find regions promoting condensation. Using advanced computational methods to predict the PS propensity of proteins, we designed a set of experiments to investigate the contributions of Prion-Like Domains (PrLDs) and RNA-binding domains (RBDs). We found that one PrLD is sufficient to drive PS, whereas multiple RBDs are needed to modulate the dynamics of the assemblies. In the case of stress granule protein Pub1 we show that the PrLD promotes sequestration of protein partners and the RBD confers liquid-like behaviour to the condensate. Our work sheds light on the fine interplay between RBDs and PrLD to regulate formation of membrane-less organelles, opening up the avenue for their manipulation.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Structural analysis of SARS-CoV-2 genome and predictions of the human interactome

  • Vandelli, Andrea|||0000-0002-8879-0144
  • Monti, Michele
  • Milanetti, Edoardo
  • Armaos, Alexandros|||0000-0003-0607-5663
  • Rupert, Jakob
  • Zacco, Elsa
  • Bechara, Elias
  • Delli Ponti, Riccardo
  • Tartaglia, Gian Gaetano|||0000-0001-7524-6310
Specific elements of viral genomes regulate interactions within host cells. Here, we calculated the secondary structure content of.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Zooming in on protein-RNA interactions, a multi-level workflow to identify interaction partners

  • Colantoni, Alessio|||0000-0001-7402-0176
  • Rupert, Jakob
  • Vandelli, Andrea|||0000-0002-8879-0144
  • Tartaglia, Gian Gaetano|||0000-0001-7524-6310
  • Zacco, Elsa
Interactions between proteins and RNA are at the base of numerous cellular regulatory and functional phenomena. The investigation of the biological relevance of non-coding RNAs has led to the identification of numerous novel RNA-binding proteins (RBPs). However, defining the RNA sequences and structures that are selectively recognised by an RBP remains challenging, since these interactions can be transient and highly dynamic, and may be mediated by unstructured regions in the protein, as in the case of many non-canonical RBPs. Numerous experimental and computational methodologies have been developed to predict, identify and verify the binding between a given RBP and potential RNA partners, but navigating across the vast ocean of data can be frustrating and misleading. In this mini-review, we propose a workflow for the identification of the RNA binding partners of putative, newly identified RBPs. The large pool of potential binders selected by in-cell experiments can be enriched by in silico tools such as cat RAPID, which is able to predict the RNA sequences more likely to interact with specific RBP regions with high accuracy. The RNA candidates with the highest potential can then be analysed in vitro to determine the binding strength and to precisely identify the binding sites. The results thus obtained can furthermore validate the computational predictions, offering an all-round solution to the issue of finding the most likely RNA binding partners for a newly identified potential RBP.